The Lewy body in Parkinson's disease and related neurodegenerative disorders
K Wakabayashi, K Tanji, S Odagiri, Y Miki, F Mori… - Molecular …, 2013 - Springer
The histopathological hallmark of Parkinson's disease (PD) is the presence of fibrillar
aggregates referred to as Lewy bodies (LBs), in which α-synuclein is a major constituent …
aggregates referred to as Lewy bodies (LBs), in which α-synuclein is a major constituent …
Protein degradation pathways in Parkinson's disease: curse or blessing
Protein misfolding, aggregation and deposition are common disease mechanisms in many
neurodegenerative diseases including Parkinson's disease (PD). Accumulation of damaged …
neurodegenerative diseases including Parkinson's disease (PD). Accumulation of damaged …
Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death
Increased autophagic vacuoles (AVs) occur in injured or degenerating neurons, under both
developmental and pathological situations. Although regulation of starvation-induced …
developmental and pathological situations. Although regulation of starvation-induced …
Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
OA Levy, C Malagelada, LA Greene - Apoptosis, 2009 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder. Neuronal cell death in
PD is still poorly understood, despite a wealth of potential pathogenic mechanisms and …
PD is still poorly understood, despite a wealth of potential pathogenic mechanisms and …
Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome
Proteasomal dysfunction may play a role in neurodegenerative conditions and protein
aggregation. Overexpression in neuronal cells of α-synuclein, a molecule linked to …
aggregation. Overexpression in neuronal cells of α-synuclein, a molecule linked to …
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
WJ Burke, VB Kumar, N Pandey, WM Panneton… - Acta …, 2008 - Springer
Parkinson's disease (PD) is a neurodegenerative disease characterized by the selective
loss of dopamine (DA) neurons and the presence of α-synuclein (AS) aggregates as Lewy …
loss of dopamine (DA) neurons and the presence of α-synuclein (AS) aggregates as Lewy …
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
T Pan, S Kondo, W Zhu, W Xie, J Jankovic, W Le - Neurobiology of disease, 2008 - Elsevier
The ubiquitin–proteasome system (UPS) and the autophagy-lysosomal pathway (ALP) are
the two most important cellular mechanisms for protein degradation. To investigate the role …
the two most important cellular mechanisms for protein degradation. To investigate the role …
Proteasome system of protein degradation and processing
AV Sorokin, ER Kim, LP Ovchinnikov - Biochemistry (Moscow), 2009 - Springer
In eukaryotic cells, degradation of most intracellular proteins is realized by proteasomes.
The substrates for proteolysis are selected by the fact that the gate to the proteolytic chamber …
The substrates for proteolysis are selected by the fact that the gate to the proteolytic chamber …
C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease
AJ Harrington, S Hamamichi… - … dynamics: an official …, 2010 - Wiley Online Library
Parkinson's disease (PD) is an age‐related movement disorder resulting, in part, from
selective loss of dopaminergic neurons. Both invertebrate and mammalian models have …
selective loss of dopaminergic neurons. Both invertebrate and mammalian models have …
The proteasome inhibition model of Parkinson's disease
E Bentea, L Verbruggen… - Journal of Parkinson's …, 2017 - content.iospress.com
The pathological hallmarks of Parkinson's disease are the progressive loss of nigral
dopaminergic neurons and the formation of intracellular inclusion bodies, termed Lewy …
dopaminergic neurons and the formation of intracellular inclusion bodies, termed Lewy …